In addition to clinical symptoms, serologic biomarkers are specific for T1D patients, among others, antibodies to glutamic acid decarboxylase (GAD), which often are present prior to the clinical diagnosis [9]. The gene discussed is GAD1; the disease is type 1 diabetes mellitus.